Matsushita Hiroki, Saku Keita, Nishikawa Takuya, Unoki Takashi, Yokota Shohei, Sato Kei, Morita Hidetaka, Yoshida Yuki, Fukumitsu Masafumi, Uemura Kazunori, Kawada Toru, Kikuchi Atsushi, Yamaura Ken
Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan.
Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan.
J Cardiol. 2025 Feb;85(2):100-107. doi: 10.1016/j.jjcc.2024.07.008. Epub 2024 Aug 2.
Impella (Abiomed, Danvers, MA, USA) is a percutaneous ventricular assist device commonly used in cardiogenic shock, providing robust hemodynamic support, improving the systemic circulation, and relieving pulmonary congestion. Maintaining adequate left ventricular (LV) filling is essential for optimal hemodynamic support by Impella. This study aimed to investigate the impact of pulmonary vascular resistance (PVR) and right ventricular (RV) function on Impella-supported hemodynamics in severe biventricular failure using cardiovascular simulation.
We used Simulink® (Mathworks, Inc., Natick, MA, USA) for the simulation, incorporating pump performance of Impella CP determined using a mock circulatory loop. Both systemic and pulmonary circulation were modeled using a 5-element resistance-capacitance network. The four cardiac chambers were represented by time-varying elastance with unidirectional valves. In the scenario of severe LV dysfunction (LV end-systolic elastance set at a low level of 0.4 mmHg/mL), we compared the changes in right (RAP) and left atrial pressures (LAP), total systemic flow, and pressure-volume loop relationship at varying degrees of RV function, PVR, and Impella flow rate.
The simulation results showed that under low PVR conditions, an increase in Impella flow rate slightly reduced RAP and LAP and increased total systemic flow, regardless of RV function. Under moderate RV dysfunction and high PVR conditions, an increase in Impella flow rate elevated RAP and excessively reduced LAP to induce LV suction, which limited the increase in total systemic flow.
PVR is the primary determinant of stable and effective Impella hemodynamic support in patients with severe biventricular failure.
Impella(美国马萨诸塞州丹弗斯市的Abiomed公司生产)是一种常用于心源性休克的经皮心室辅助装置,可提供强大的血流动力学支持,改善体循环并缓解肺淤血。维持足够的左心室(LV)充盈对于Impella实现最佳血流动力学支持至关重要。本研究旨在使用心血管模拟研究肺血管阻力(PVR)和右心室(RV)功能对严重双心室衰竭患者Impella支持下的血流动力学的影响。
我们使用Simulink®(美国马萨诸塞州纳蒂克市的Mathworks公司)进行模拟,纳入了使用模拟循环回路确定的Impella CP的泵性能。体循环和肺循环均使用五元件电阻-电容网络进行建模。四个心腔由具有单向瓣膜的时变弹性表示。在严重左心室功能障碍(左心室收缩末期弹性设定为低水平0.4 mmHg/mL)的情况下,我们比较了不同程度的右心室功能、肺血管阻力和Impella流速下右心房压力(RAP)和左心房压力(LAP)、总体循环流量以及压力-容积环关系的变化。
模拟结果表明,在低肺血管阻力条件下,无论右心室功能如何,Impella流速增加会略微降低RAP和LAP并增加总体循环流量。在中度右心室功能障碍和高肺血管阻力条件下,Impella流速增加会升高RAP并过度降低LAP以诱发左心室抽吸,这限制了总体循环流量的增加。
肺血管阻力是严重双心室衰竭患者Impella血流动力学支持稳定有效的主要决定因素。